|
If you are interested in
participating in this study,
contact our research coordinator using the
information shown below.
Study
number:
|
IRB 06-0528
|
Principal
Investigator:
|
David
B. Peden, MD
|
Description:
|
Allergen
extracts, including dust mite allergen
extract are FDA approved therapies for injection immunotherapy for
inflammation
and irritation of the nose caused by allergies. Likewise, such extracts
have
been used in research studies involving oral or nasal inhalation to evaluate
inflammatory and immune processes involved in allergic inflammation.
The purpose of this research study is to learn
more about the effect of inhaled dust mite allergen extract on airway responses
in allergic individuals with mild asthma. Information learned
from this study will be
used to identify a safe dose range of this extract for use in
inhalation challenge studies. This study
will also help determine how
inhalation of the allergen affects mucociliary clearance which is a
measure of how quickly mucus clears from the airway. |
Contact:
|
(919)-966-2879
or email dustallergystudy@med.unc.edu
|
| Requirements: |
- You must be between 18 and 50
- You should have mild
asthma and be allergic to dust mites, but be otherwise
healthy with no chronic illness
- You should not be
pregnant or nursing
- You should not have had an upper respiratory
tract
infection in the past month
|
Time
Commitment:
|
Six
visits over
a 2-3 week period which will include an overnight stay at the General Clinical Research
Center
at UNC Hospitals
|
Compensation:
|
Volunteers
completing all
study procedures will be compensated up to $750.00
|
|
Review the
Informed Consent Form:
|
IRB 06-0528
informed consent form |
|
